Bevacizumab/paclitaxel: Nasal septum perforation: case report

Author：  

Publisher： Adis International

ISSN： 0114-9954

Source： Reactions Weekly, Vol.1, Iss.1388, 2012-01, pp. : 9-9

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Bevacizumab/docetaxel/paclitaxel: Nasal septum perforation (first report with paclitaxel): 5 case reports

By  

Reactions Weekly, Vol. 1, Iss. 1323, 2010-01 ,pp. : 11-12

Adis International

Access to resources Recommend Favorite

Bevacizumab: Fusariosis (first report) and nasal septum perforation: case report

By  

Reactions Weekly, Vol. 1, Iss. 1167, 2007-01 ,pp. : 8-8

Adis International

Access to resources Recommend Favorite

Bevacizumab/paclitaxel: Various toxicities: 8 case reports

By  

Reactions Weekly, Vol. 1, Iss. 1423, 2012-01 ,pp. : 13-13

Adis International

Access to resources Recommend Favorite

Bevacizumab: Colonic perforation: case report

By  

Reactions Weekly, Vol. 1, Iss. 1339, 2011-01 ,pp. : 11-11

Adis International

Access to resources Recommend Favorite

Bevacizumab: Bladder perforation: case report

By  

Reactions Weekly, Vol. 1, Iss. 1341, 2011-01 ,pp. : 9-9

Adis International

Access to resources Recommend Favorite